Home › Companies › CYDY

CytoDyn

CYDY Lead: Phase 2 ★ Read the deep dive → 4 Biotech Distilled articles ↓

Neurology Oncology Protein

Pipeline (3 active programs)

leronlimab

Protein Target: CCR5

Colorectal Cancer Phase 2
Triple-Negative Breast Cancer
Alzheimer's Disease Phase 2 subcutaneous

Biotech Distilled coverage (4)

2026-06-04 UPDATE: CytoDyn (CYDY) - Natera Puts Its Name on the ctDNA Story
2026-05-01 UPDATE: CytoDyn (CYDY) - The Tumor Biopsy I Asked For 🔒 Paid
2026-04-27 UPDATE: CytoDyn (CYDY) - The Lie Detector Test Beeped Green 🔒 Paid
2026-04-21 CytoDyn (CYDY) - Scientific Deep Dive for Leronlimab and Pipeline Products

Articles open on Substack. Some deep dives are subscriber-only.